AAAAAA

   
Results: 1-16 |
Results: 16
Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy
Authors: Ulrich-Pur, H Kornek, GV Fiebiger, W Gedlicka, C Raderer, M Lenauer, A Depisch, D Lang, F Pidlich, J Scheithauer, W
Citation: H. Ulrich-pur et al., Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy, ANN ONCOL, 12(9), 2001, pp. 1269-1272
Second-line treatment with oxaliplatin plus raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy
Authors: Scheithauer, W Kornek, GV Schuell, B Ulrich-Pur, H Penz, M Raderer, M Lang, F Schneeweiss, B Lenauer, A Depisch, D
Citation: W. Scheithauer et al., Second-line treatment with oxaliplatin plus raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy, ANN ONCOL, 12(5), 2001, pp. 709-714
Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy
Authors: Penz, M Kornek, GV Raderer, M Ulrich-Pur, H Fiebiger, W Scheithauer, W
Citation: M. Penz et al., Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy, ANN ONCOL, 12(3), 2001, pp. 421-422
Phase II trial of two-weekly gemcitabine in patients with advanced biliarytract cancer
Authors: Penz, M Kornek, GV Raderer, M Ulrich-Pur, H Fiebiger, W Lenauer, A Depisch, D Krauss, G Schneeweiss, B Scheithauer, W
Citation: M. Penz et al., Phase II trial of two-weekly gemcitabine in patients with advanced biliarytract cancer, ANN ONCOL, 12(2), 2001, pp. 183-186
Treatment of advanced breast cancer with vinorelbine and docetaxel with orwithout human granulocyte colony-stimulating factor
Authors: Kornek, GV Ulrich-Pur, H Penz, M Haider, K Kwasny, W Depisch, D Kovats, E Lang, F Schneeweiss, B Scheithauer, W
Citation: Gv. Kornek et al., Treatment of advanced breast cancer with vinorelbine and docetaxel with orwithout human granulocyte colony-stimulating factor, J CL ONCOL, 19(3), 2001, pp. 621-627
Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine
Authors: Kornek, GV Potter, R Selzer, E Schratter, A Ulrich-Pur, H Rogy, M Kraus, G Scheithauer, W
Citation: Gv. Kornek et al., Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine, INT J RAD O, 49(3), 2001, pp. 665-671
Treatment of advanced hepatocellular carcinoma with biweekly high-dose gemcitabine
Authors: Ulrich-Pur, H Kornek, GV Fiebiger, W Schull, B Raderer, M Scheithauer, W
Citation: H. Ulrich-pur et al., Treatment of advanced hepatocellular carcinoma with biweekly high-dose gemcitabine, ONCOL-BASEL, 60(4), 2001, pp. 313-315
Oxaliplatin-induced fever and release of IL-6 (vol 59, pg 187, 2000)
Authors: Ulrich-Pur, H Penz, M Fiebiger, WCC Schull, B Kornek, GV Scheithauer, W Raderer, M
Citation: H. Ulrich-pur et al., Oxaliplatin-induced fever and release of IL-6 (vol 59, pg 187, 2000), ONCOL-BASEL, 60(2), 2001, pp. 145-145
Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma - Results of a phase I-II trial
Authors: Scheithauer, W Kornek, GV Ulrich-Pur, H Penz, M Raderer, M Salek, T Haider, K Kwasny, W Depisch, D
Citation: W. Scheithauer et al., Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma - Results of a phase I-II trial, CANCER, 91(7), 2001, pp. 1264-1271
Treatment of advanced, refractory breast cancer with alternating docetaxeland epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor
Authors: Kwasny, W Kornek, G Haider, K Valencak, J Ulrich-Pur, H Penz, M Lang, F Depisch, D Scheithauer, W
Citation: W. Kwasny et al., Treatment of advanced, refractory breast cancer with alternating docetaxeland epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor, BREAST CANC, 63(3), 2000, pp. 235-241
Distribution of patients with Wilson disease carrying the H1069Q mutation in Austria
Authors: Cauza, E Ulrich-Pur, H Polli, C Gangl, A Ferenci, P
Citation: E. Cauza et al., Distribution of patients with Wilson disease carrying the H1069Q mutation in Austria, WIEN KLIN W, 112(13), 2000, pp. 576-579
Oxaliplatin-induced fever and release of IL-6
Authors: Ulrich-Pur, H Fiebiger, WCC Schull, B Kornek, GV Scheithauer, W Raderer, M
Citation: H. Ulrich-pur et al., Oxaliplatin-induced fever and release of IL-6, ONCOL-BASEL, 59(3), 2000, pp. 187-189
Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factor
Authors: Hejna, M Kornek, GV Raderer, M Ulrich-Pur, H Fiebiger, WCC Marosi, L Schneeweiss, B Greul, R Scheithauer, W
Citation: M. Hejna et al., Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factor, CANCER, 89(3), 2000, pp. 516-522
A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma
Authors: Ulrich-Pur, H Kornek, GV Raderer, M Haider, K Kwasny, W Depisch, D Greul, R Schneeweiss, B Krauss, G Funovics, J Scheithauer, W
Citation: H. Ulrich-pur et al., A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma, CANCER, 88(11), 2000, pp. 2505-2511
Gemcitabine for the treatment of advanced biliary tract carcinomas: Evaluation of two different dose regimens
Authors: Valencak, J Kornek, GV Raderer, M Ulrich-Pur, H Krauss, G Greul, R Pidlich, J Pfeffel, F Haider, K Kwasny, W Schneeweiss, B Scheithauer, W
Citation: J. Valencak et al., Gemcitabine for the treatment of advanced biliary tract carcinomas: Evaluation of two different dose regimens, ONKOLOGIE, 22(6), 1999, pp. 498-501
Treatment of advanced gastric cancer with oral idarubicin, leucovorin, andtegafur
Authors: Ulrich-Pur, H Raderer, M Kornek, GV Haider, K Kwasny, W Krauss, G Scheithauer, W
Citation: H. Ulrich-pur et al., Treatment of advanced gastric cancer with oral idarubicin, leucovorin, andtegafur, ONKOLOGIE, 22(4), 1999, pp. 292-294
Risultati: 1-16 |